James G. Jackson

5.2k citations

70 papers · 3.8k indexed · h-index 36

Impact in

Endocrinology, Diabetes and Metabolism top 1%
- Growth Hormone and Insulin-like Growth Factors
Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism

Papers in

Biotechnology 11
- Cancer Research and Treatments 11
Cancer Research 16
- Cancer, Hypoxia, and Metabolism 10

Co-authors: Douglas Yee Guillermina Lozano Adrian V. Lee Olivia M. Pereira‐Smith Ashkan Shahbandi Susan G. Hilsenbeck José A. Figueroa Morris F. White
Journals: Cancer Research (3 papers)Oncogene (3 papers)JNCI Journal of the National Cancer Institute (2 papers)Trends in cancer (2 papers)Journal of Biological Chemistry (2 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

James G. Jackson

67 papers receiving 3.8k citations

Peers

Countries citing papers authored by James G. Jackson

Since Specialization

Citations

This map shows the geographic impact of James G. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James G. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James G. Jackson more than expected).

Fields of papers citing papers by James G. Jackson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James G. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James G. Jackson. The network helps show where James G. Jackson may publish in the future.

Co-authors

The 25 scholars most cited alongside James G. Jackson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James G. Jackson Line = papers co-authored together James G. Jackson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Could senescence phenotypes strike the balance to promote tumor dormancy? Cancer and Metastasis Reviews ·秀夫石田, L. A. Almeida, Charles W. Shey, Ashkan Shahbandi, James G. Jackson	2023	4
2	Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional data Disease Models & Mechanisms ·Lu Rp, Raheleh Amirkhah, James G. Jackson, Tamsin R.M. Lannagan, Kathryn Gilroy, Sudhir B. Malla, Keara L. Redmond, Shahid Ameer Iftikhar Hussian Gul, Simon S. McDade, Tim Maughan, Simon J. Leedham, Andrew D. Campbell, Owen J. Sansom, Mark Lawler, Philip D. Dunne	2022	3
3	Analysis across multiple tumor types provides no evidence that mutant p53 exerts dominant negative activity npj Precision Oncology ·Ashkan Shahbandi, James G. Jackson	2018	51
4	p53 Mediates Vast Gene Expression Changes That Contribute to Poor Chemotherapeutic Response in a Mouse Model of Breast Cancer Translational Oncology ·Crystal A. Tonnessen-Murray, Nathan Ungerleider, Sabine Wellner, Amanda R. Wasylishen, Wesley D. Frey, James G. Jackson	2018	13
5	SASP: Tumor Suppressor or Promoter? Yes! Trends in cancer ·Sabine Wellner, James G. Jackson	2016	158
6	The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence Cold Spring Harbor Perspectives in Medicine ·Crystal A. Tonnessen-Murray, Guillermina Lozano, James G. Jackson	2016	52
7	A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults Bipolar Disorders ·James G. Jackson, Francisco J. Díaz, Lucelly López, José de León	2015	81
8	Therapeutic Efficacy of p53 Restoration in Mdm2 -Overexpressing Tumors Molecular Cancer Research ·Qin Li, Yun Zhang, Adel K. El‐Naggar, Shunbin Xiong, Peirong Yang, James G. Jackson, Gilda P. Chau, Guillermina Lozano	2014	25
9	The p53–Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity Genes & Development ·Vinod Pant, Shunbin Xiong, James G. Jackson, Sean M. Post, Hussein A. Abbas, Alfonso Quintás‐Cardama, A. N. Hamir, Guillermina Lozano	2013	71
10	Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation Journal of Clinical Investigation ·Yongxing Wang, Young‐Ah Suh, Tracey Shatte, James G. Jackson, Shunbin Xiong, Tamara Terzian, Alfonso Quintás‐Cardama, James A. Bankson, Adel K. El‐Naggar, Guillermina Lozano	2011	106
11	Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity Journal of Lipid Research ·Lan Hong, Cliff C. Cheng, Timothy J. Kowalski, Ling Pang, Li-Xin Shan, Cheng‐Chi Chuang, James G. Jackson, Alberto Rojas-Triana, Loretta A. Bober, Li Liu, Johannes Voigt, Peter Orth, Xianshu Yang, Tatiana Morais, Joseph A. Hedrick	2011	72
12	Fine-scale quantification of HCG beta gene transcription in human trophoblastic and non-malignant non-trophoblastic tissues Molecular Human Reproduction ·Kristiina Rull, Pille Hallast, Faraz Hamid, James G. Jackson, Margus Punab, Andres Salumets, R. Keith Campbell, Maris Laan	2007	30
13	Law for educators : school and university law in Australia ePublications@SCU (Southern Cross University) ·James G. Jackson, Aarón Santiago-León	2007	3
14	p53 Is Preferentially Recruited to the Promoters of Growth Arrest Genes p21 and GADD45 during Replicative Senescence of Normal Human Fibroblasts Cancer Research ·James G. Jackson, Olivia M. Pereira‐Smith	2006	121
15	Directors duties to the company and minority shareholder environmental activism ePublications@SCU (Southern Cross University) ·G Frija, Steffen Görres, James G. Jackson, 矢羽々崇	2005	2
16	Blockade of Epidermal Growth Factor- or Heregulin-Dependent ErbB2 Activation with the Anti-ErbB2 Monoclonal Antibody 2C4 Has Divergent Downstream Signaling and Growth Effects Cancer Research ·James G. Jackson, Patricia St. Clair, Mark X. Sliwkowski, Michael G. Brattain	2004	83
17	Insulin Receptor Substrate-1 is the Predominant Signaling Molecule Activated by Insulin-like Growth Factor-I, Insulin, and Interleukin-4 in Estrogen Receptor-positive Human Breast Cancer Cells Journal of Biological Chemistry ·James G. Jackson, Morris F. White, Douglas Yee	1998	152
18	Use of Insulin-like Growth Factor-I Gene Expression to Distinguish Between Breast and Ovarian Cancer The American Journal of the Medical Sciences ·Douglas Yee, James G. Jackson, Daniel D. Von Hoff, Peter M. Ravdin	1994	1
19	Behavioral assessments of two drug combinations for oral sedation. PubMed ·Козьменко Наталья Валериевна, H. Hoek, James G. Jackson, Sarah Mifsud	1993	37
20	Recombinant insulin‐like growth factor binding protein‐1 inhibits IGF‐I, serum, and estrogen‐dependent growth of MCF‐7 human breast cancer cells Journal of Cellular Physiology ·José A. Figueroa, A. Kovács, James G. Jackson, Martin J. McDermott, Susan G. Hilsenbeck, Douglas Yee	1993	68

About James G. Jackson

James G. Jackson is a scholar working on Biotechnology, Cancer Research, Oncology, Law and Endocrinology, Diabetes and Metabolism, having authored 70 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (21 papers), Growth Hormone and Insulin-like Growth Factors (15 papers), Cancer Research and Treatments (11 papers), Metabolism, Diabetes, and Cancer (10 papers), Cancer, Hypoxia, and Metabolism (10 papers), Telomeres, Telomerase, and Senescence (9 papers), Legal Education and Practice Innovations (7 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (970 citations), Cancer Research (818 citations), Oncology (1.5k citations), Aging (81 citations) and Molecular Biology (2.4k citations). James G. Jackson has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Douglas Yee, Guillermina Lozano, Adrian V. Lee, Olivia M. Pereira‐Smith, Ashkan Shahbandi, Susan G. Hilsenbeck, José A. Figueroa, Morris F. White, Adel K. El‐Naggar and Toshiyuki Yoneda. Their work appears in journals such as Cancer Research, Oncogene, JNCI Journal of the National Cancer Institute, Trends in cancer and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact